FAS and neoplasm: Orlistat is a novel inhibitor of the thioesterase domain of FAS that inhibited prostate cancer cell proliferation, induced apoptosis, and inhibited the growth of PC-3 human tumour xenografts implanted in nude mice (Kridel et al, 2004).